Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Terlipressin on Cerebral Oxygen Saturation and Cerebral Blood Flow During Living Donor Liver Transplantation

NCT03395574 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.

NCT NCT03395574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03395574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Terlipressin on Cerebral Oxygen Saturation and Cerebral Blood Flow During Living Donor Liver Transplantation
Lead sponsor
Kasr El Aini Hospital
Phase
Phase 2
Overall status
Completed
Start date
January 25, 2018
Completion date
November 25, 2018
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplantation, terlipressin adverse reaction